BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 30485330)

  • 1. Evaluation of transcriptionally regulated genes identifies NCOR1 in hormone receptor negative breast tumors and lung adenocarcinomas as a potential tumor suppressor gene.
    Noblejas-López MDM; Morcillo-García S; Nieto-Jiménez C; Nuncia-Cantarero M; Győrffy B; Galan-Moya EM; Pandiella A; Ocaña A
    PLoS One; 2018; 13(11):e0207776. PubMed ID: 30485330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormally localized DLK1 interacts with NCOR1 in non-small cell lung cancer cell nuclear.
    Tan J; Zhang S; Li L; Mu J; Wang Z; Zhang L; Jiang M; Li W; Yang X; Liu Y; Gao Y
    Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31661545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NCOR1 mRNA is an independent prognostic factor for breast cancer.
    Zhang Z; Yamashita H; Toyama T; Sugiura H; Ando Y; Mita K; Hamaguchi M; Hara Y; Kobayashi S; Iwase H
    Cancer Lett; 2006 Jun; 237(1):123-9. PubMed ID: 16019133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cell type-specific expression map of NCoR1 and SMRT transcriptional co-repressors in the mouse brain.
    Iemolo A; Montilla-Perez P; Lai IC; Meng Y; Nolan S; Wen J; Rusu I; Dulcis D; Telese F
    J Comp Neurol; 2020 Sep; 528(13):2218-2238. PubMed ID: 32072640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear corepressor 1 expression predicts response to first-line endocrine therapy for breast cancer patients on relapse.
    Zhang ZH; Yamashita H; Toyama T; Yamamoto Y; Kawasoe T; Ibusuki M; Tomita S; Sugiura H; Kobayashi S; Fujii Y; Iwase H
    Chin Med J (Engl); 2009 Aug; 122(15):1764-8. PubMed ID: 19781322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen.
    Girault I; Lerebours F; Amarir S; Tozlu S; Tubiana-Hulin M; Lidereau R; Bièche I
    Clin Cancer Res; 2003 Apr; 9(4):1259-66. PubMed ID: 12684393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NCOR1 modulates erythroid disorders caused by mutations of thyroid hormone receptor α1.
    Han CR; Park S; Cheng SY
    Sci Rep; 2017 Dec; 7(1):18080. PubMed ID: 29273766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer plasticity is restricted by a LATS1-NCOR1 repressive axis.
    Aylon Y; Furth N; Mallel G; Friedlander G; Nataraj NB; Dong M; Hassin O; Zoabi R; Cohen B; Drendel V; Salame TM; Mukherjee S; Harpaz N; Johnson R; Aulitzky WE; Yarden Y; Shema E; Oren M
    Nat Commun; 2022 Nov; 13(1):7199. PubMed ID: 36443319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PDCD2 and NCoR1 as putative tumor suppressors in gastric gastrointestinal stromal tumors.
    Wang W; Song XW; Bu XM; Zhang N; Zhao CH
    Cell Oncol (Dordr); 2016 Apr; 39(2):129-37. PubMed ID: 26589942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoregulatory loop of nuclear corepressor 1 expression controls invasion, tumor growth, and metastasis.
    Martínez-Iglesias OA; Alonso-Merino E; Gómez-Rey S; Velasco-Martín JP; Martín Orozco R; Luengo E; García Martín R; Ibáñez de Cáceres I; Fernández AF; Fraga MF; González-Peramato P; Varona C; Palacios J; Regadera J; Aranda A
    Proc Natl Acad Sci U S A; 2016 Jan; 113(3):E328-37. PubMed ID: 26729869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor suppressive actions of the nuclear receptor corepressor 1.
    Martínez-Iglesias O; Alonso-Merino E; Aranda A
    Pharmacol Res; 2016 Jun; 108():75-79. PubMed ID: 27149915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear Receptor Corepressor 1 Expression and Output Declines with Prostate Cancer Progression.
    Lopez SM; Agoulnik AI; Zhang M; Peterson LE; Suarez E; Gandarillas GA; Frolov A; Li R; Rajapakshe K; Coarfa C; Ittmann MM; Weigel NL; Agoulnik IU
    Clin Cancer Res; 2016 Aug; 22(15):3937-49. PubMed ID: 26968201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Estrogen Receptor Cofactor SPEN Functions as a Tumor Suppressor and Candidate Biomarker of Drug Responsiveness in Hormone-Dependent Breast Cancers.
    Légaré S; Cavallone L; Mamo A; Chabot C; Sirois I; Magliocco A; Klimowicz A; Tonin PN; Buchanan M; Keilty D; Hassan S; Laperrière D; Mader S; Aleynikova O; Basik M
    Cancer Res; 2015 Oct; 75(20):4351-63. PubMed ID: 26297734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nuclear corepressor 1 and the thyroid hormone receptor β suppress breast tumor lymphangiogenesis.
    Martínez-Iglesias O; Olmeda D; Alonso-Merino E; Gómez-Rey S; González-López AM; Luengo E; Soengas MS; Palacios J; Regadera J; Aranda A
    Oncotarget; 2016 Nov; 7(48):78971-78984. PubMed ID: 27806339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ASCL1-coexpression profiling but not single gene expression profiling defines lung adenocarcinomas of neuroendocrine nature with poor prognosis.
    Fujiwara T; Hiramatsu M; Isagawa T; Ninomiya H; Inamura K; Ishikawa S; Ushijima M; Matsuura M; Jones MH; Shimane M; Nomura H; Ishikawa Y; Aburatani H
    Lung Cancer; 2012 Jan; 75(1):119-25. PubMed ID: 21737174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haploinsufficiency of NCOR1 associated with autism spectrum disorder, scoliosis, and abnormal palatogenesis.
    Sakaguchi Y; Uehara T; Suzuki H; Sakamoto Y; Fujiwara M; Kosaki K; Takenouchi T
    Am J Med Genet A; 2018 Nov; 176(11):2466-2469. PubMed ID: 30289594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LKB1 loss by alteration of the NKX2-1/p53 pathway promotes tumor malignancy and predicts poor survival and relapse in lung adenocarcinomas.
    Tsai LH; Chen PM; Cheng YW; Chen CY; Sheu GT; Wu TC; Lee H
    Oncogene; 2014 Jul; 33(29):3851-60. PubMed ID: 23995788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NCoR1 and SMRT play unique roles in thyroid hormone action in vivo.
    Shimizu H; Astapova I; Ye F; Bilban M; Cohen RN; Hollenberg AN
    Mol Cell Biol; 2015 Feb; 35(3):555-65. PubMed ID: 25421714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nuclear receptor corepressor NCoR1 regulates hematopoiesis and leukemogenesis in vivo.
    Wan X; Liu L; Zhou P; Hui X; He Q; Yu F; Zhang W; Ding X; Yuan X; Zhang N; Zhao Y; Zhu R; Liu Y; Hao P; Auwerx J; Song X; Leng Q; Zhang Y
    Blood Adv; 2019 Feb; 3(4):644-657. PubMed ID: 30804018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic analyses of differences between solid and nonsolid predominant lung adenocarcinomas.
    Luo J; Ma K; Shi Y; Chen Z; Zhao M; Huang Y; Wang S; Xi J; Zhan C; Xu S; Wang Q
    Thorac Cancer; 2018 Dec; 9(12):1656-1663. PubMed ID: 30276966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.